# Beijing Novogene Bioinformatics Technology

Beijing Novogene Bioinformatics Technology is a Corporate Investor based in Beijing, China.

## Overview

- **Organization type:** Corporate Investor
- **Headquarters:** Beijing, China
- **Region:** Asia
- **Address:** Beijing, China
- **Founded:** 2011
- **Assets under management:** Undisclosed
- **Website:** novogene.com
- **LinkedIn:** https://www.linkedin.com/company/novogene

## Regulatory record

- **Reports private funds:** No

## About

Beijing Novogene Bioinformatics Technology was established in 2011 by Dr. Li Ruiqiang. The founder serves as chairman and chief executive. The firm delivers genomic technology services, tumor detection and genetic testing. Asset deployment occurs through direct operations and co-investments with SDIC Innovation, CMB International Capital and Sigma Square Capital. Geographic reach covers China, Hong Kong, the United States and the United Kingdom. Additional facilities include a Tianjin medical laboratory, Cambridge Sequencing Center and Sacramento Sequencing Center. No recent operational events from the last 24 months appear in available records. The corporate structure ties investment activity directly to the operating company's sequencing platform and high-performance computing assets.

## Sectors

- Healthcare Services

## Offices

- Hong Kong
- United States
- United Kingdom

## People

- Dr. Li Ruiqiang — Founder, Chairman, and CEO

## Questions

### Who runs investment decisions at Beijing Novogene Bioinformatics Technology?

Dr. Li Ruiqiang serves as founder, chairman and CEO. Investment activity aligns with the firm's core sequencing and testing operations.

### Does Beijing Novogene Bioinformatics Technology participate in fund commitments or only direct deals?

Activity centers on direct operational investments and select institutional partnerships. SDIC Innovation and CMB International Capital participated in funding rounds.

### Where does Beijing Novogene Bioinformatics Technology maintain sequencing facilities?

Facilities operate in Beijing, Tianjin, Cambridge in the United Kingdom and Sacramento in the United States.

### Which institutional investors have backed Beijing Novogene Bioinformatics Technology?

SDIC Innovation, CMB International Capital and Sigma Square Capital have participated in funding rounds.

## Related profiles

- [Beijing Qi Xin Investment and Development](https://altss.com/profile/beijing-qi-xin-investment-and-development)

---

Last updated: 2026-06-03T20:00:00.000Z

Canonical page: https://altss.com/profile/beijing-novogene-bioinformatics-technology

Maintained by Altss — https://altss.com — methodology: https://altss.com/methodology